making accurate, valuable information accessible
Well, frankly, not much.
Medical education (med ed) agencies are virtually the same as medical communications agencies, and at Rx Communications we call ourselves by either term. Some med ed agencies focus on delivering marketing & training materials that help pharmaceutical and medical devices companies educate patients, subscribers and payers not only about their product but also about disease awareness. Other medical communications agencies may concentrate on developing the scientific platform for key opinion leaders (KOLs), which would include scientific and clinical journal publications as well as congress materials. Yet others may focus on clinical trial documents and regulatory materials. With our range of writer expertise and superb project management, we can manage it all. We deliver quality clinical and pre-clinical study protocols, reports and investigator materials, alongside medical communications and medical education in whatever format our clients want.
Our only criterion is that the project in question has a valid scientific foundation so that whatever we do adds to an evidence base that supports and encourages good healthcare information and decision-making.
EBM or evidence-based medicine is vital for improving healthcare. And so much of it now incorporates the use of big data and outcomes research. The sheer volume of data can make the job of communication a tricky one – data selection is vital but must not bias the evidence. This is where publications planning and communications strategy comes in.
Initially, the focus should be on understanding how, when and why healthcare decisions are made – and of course, who makes them. By healthcare decisions we mean decisions right from the top, e.g. government policy, regulatory authorities, formulary committees etc. right down to the selection of a particular wound covering made by a nurse, a prescription by a subscriber, or an OTC (over the counter) healthcare product decision made by a patient/consumer.
A medical communications agency worth its salt should help find the answers to these questions, take the evidence available, perform the necessary competitor and benchmarking analyses and be able to come up with a publications plan and/or communications strategy that fulfils these criteria for the decisionmakers that are most important to the client.
Of course, to collect ALL the evidence necessary to fulfil every audience/decisionmaker in every country is an impossible task. And hugely expensive. So the next questions become: Who are the most important target audiences, and when, how and what do they need to know/understand to make healthcare decisions?
Sadly, the confidential nature of our work means that our client testimonials are anonymous, but we still think it’s important for you to know what they think of us anyway!
Started in 2018, the FDA’s “Real-Time Oncology Review (ROTR)” project gives sponsors a head start on the application review process and poses additional challenges. The ROTR helps sponsors […]
The future of specialty pharmacy in the post-pandemic world was the topic of the October 27th keynote sessions at Asembia 2021 in Las Vegas. Speakers covered how pharmacy benefit managers (PBMs) are […]
Research and Markets has released their Economic & Related Consulting Service Revenues World Report + Database, which covers products and services consumption in over 200 countries. The report is […]
It’s that time of year! Christmas is coming and once again proving beyond any doubt that time is relative – as to anyone who has grown to an age whereby…
It’s been 40 years since the first cases of HIV/AIDS were reported. Since then, thanks to advances in our understanding of the disease, improved diagnosis and treatment and effective prevention…
Rx Communications turns 21 on November 13th 2021 and we thought we’d kick off the party by finding out why the 21st birthday is such a big deal.…
As the nation’s health protection agency, CDC saves lives and protects people from health, safety, and security threats. Something interesting for those who might wonder what all the fuss is about vaccinating…
With global numbers of those living with diabetes expected to rise by more than 100 million over the next nine years, it’s never been more important to understand the impact…
Viruses and bacteria such as Streptococcus pneumoniae, Haemophilus influenzae type B and respiratory syncytial virus (RSV) are common causes of pneumonia. Pneumonia is also a complication of SARS-CoV-2 (COVID-19). Ongoing…
Get our Health Outcomes Communicator direct to your inbox – sign-up now!
Please note: we will not pass your details on to any third-parties. View our Privacy Policy here.
